|
 |
| |
 |
|
|
|
|
| |
management team
|
|
 |
R. Andrew Ramelmeier, Ph.D. |
|
| |
Vice President, Manufacturing and Process Development
Dr. Ramelmeier joined BioMarin in September 2006
as Vice President of Manufacturing and Process Development.
His responsibilities include oversight of manufacturing,
manufacturing sciences, process development, and
facilities. Prior to joining BioMarin, Dr. Ramelmeier
was vice president, Process Sciences, of the Global
Biologics Supply Chain (formerly Centocor Inc.)
at Johnson & Johnson. In this role, he oversaw
technical support of J&J's BioPharm manufacturing
plants, including process validation and tech transfer
of new and existing products, regulatory inspections,
and process improvements. From 2001 to 2005, he
served as Executive Director, Pharmaceutical Development
at Centocor, where he was responsible for pilot
plant operations, clinical and toxicology supplies,
and pilot-scale process development. In this role,
his team increased clinical manufacturing capacity
three-fold and developed scale-up capability to
meet the growing needs of the BioPharm business
in J&J. Earlier in his career, Dr. Ramelmeier
was Senior Research Fellow, Bioprocess Research
and Development at Merck & Co. Dr. Ramelmeier
received his Ph.D. degree in Chemical Engineering
at the University of California, Berkeley, and a
B.S. degree in Chemical Engineering from Johns Hopkins
University. |
|
| |
|
|
|
|
|
